Immuno-Biological Laboratories News

Immuno-Biological Laboratories: Financial results for the first quarter of the 2025 fiscal year ending in March, under the Japanese standard (consolidated).

Aug 8 02:30 ET

Immuno-Biological Laboratories: Extraordinary Report

Jun 25 21:44 ET

Immuno-Biological Laboratories: Confirmation letter

Jun 25 21:40 ET

Immuno-Biological Laboratories: Securities report - 42nd period (April 1, 2023 - March 31, 2024)

Jun 25 21:38 ET

Immuno-Biological Laboratories: Regarding the correction of some of the numerical data in the "2024 Fiscal Year End Results Briefing (Japanese Standards, Consolidated)".

Jun 18 02:30 ET

IMMUNO-BIOLOGICAL LABORATORIES: Financial results presentation materials for the fiscal year ending 2024/3 (42nd term)

May 24 01:00 ET

IMMUNO-BIOLOGICAL LABORATORIES: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

May 14 02:30 ET

IMMUNO-BIOLOGICAL LABORATORIES: Notice regarding revisions to full-year earnings forecasts

May 10 02:30 ET

Institute for Immunobiology: Confirmation

Feb 13 19:10 ET

Immunobiological Research Institute: Quarterly Report - 42nd Quarter 3rd Quarter (2023/10/01 - 2023/12/31)

Feb 13 19:07 ET

Immuno-Biological Laboratories: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

Feb 2 01:30 ET

Immuno-Biological Laboratories: 2nd quarter financial results presentation for the fiscal year ending 2024/3 (42nd period)

Nov 30, 2023 01:30 ET

Immuno-Biological Laboratories: Confirmation letter

Nov 13, 2023 19:02 ET

Immuno-Biological Laboratories: Quarterly Report - 42nd Quarter Second Quarter (2023/07/01 - 2023/09/30)

Nov 13, 2023 19:01 ET

Immuno-Biological Laboratories: Summary of Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

Nov 2, 2023 02:30 ET

Immuno-Biological Laboratories: Confirmation letter

Aug 13, 2023 20:08 ET

Immuno-Biological Laboratories: Quarterly Report - First Quarter 42 (2023/04/01 - 2023/06/30)

Aug 13, 2023 20:05 ET

Immuno-Biological Laboratories: Summary of Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

Aug 7, 2023 02:30 ET

Immuno-Biological Laboratories: Extraordinary Report

Jun 29, 2023 20:23 ET

Immuno-Biological Laboratories: Confirmation letter

Jun 29, 2023 20:17 ET